Activation of an antiviral response in normal but not transformed mouse cells: A new determinant of minute virus of mice oncotropism

Journal of Virology

Volumn 84, Issue 1, 2010, Pages 516-531

  Grekova, Svitlana ^a   Zawatzky, Rainer ^a   Hörlein, Rita ^a   Cziepluch, Celina ^a   Mincberg, Michal ^b   Davis, Claytus ^b   Rommelaere, Jean ^a   Daeffler, Laurent ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATTITUDE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIFE CYCLE; MOUSE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; TREATMENT RESPONSE; VIROGENESIS; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ANIMALS; CELL LINE, TRANSFORMED; CELLS, CULTURED; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERON-BETA; MICE; MINUTE VIRUS OF MICE; VIRUS REPLICATION;

MINUTE VIRUS OF MICE; PARVOVIRUS;

EID: 72849111528     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01618-09     Document Type: Article

References (62)

1. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-738. (Pubitemid 33009951)
2. Alsharifi, M., A. Mullbacher, and M. Regner. 2008. Interferon type I responses in primary and secondary infections. Immunol. Cell Biol. 86:239-245.
3. Balachandran, S., P. C. Roberts, L. E. Brown, H. Truong, A. K. Pattnaik, D. R. Archer, and G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-141. (Pubitemid 30953958)
4. Bodendorf, U., C. Cziepluch, J. C. Jauniaux, J. Rommelaere, and N. Salome. 1999. Nuclear export factor CRM1 interacts with nonstructural proteins NS2 from parvovirus minute virus of mice. J. Virol. 73:7769-7779.
5. Brockhaus, K., S. Plaza, D. J. Pintel, J. Rommelaere, and N. Salome. 1996. Nonstructural proteins NS2 of minute virus of mice associate in vivo with 14-3-3 protein family members. J. Virol. 70:7527-7534. (Pubitemid 26339057)
6. Cornelis, J. J., Y. Q. Chen, N. Spruyt, N. Duponchel, S. F. Cotmore, P. Tattersall, and J. Rommelaere. 1990. Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription. J. Virol. 64:2537-2544.
7. Cotmore, S. F., L. J. Sturzenbecker, and P. Tattersall. 1983. The autonomous parvovirus MVM encodes two nonstructural proteins in addition to its capsid polypeptides. Virology 129:333-343.
8. Cotmore, S. F., and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-174.
9. Critchley-Thorne, R. J., D. L. Simons, N. Yan, A. K. Miyahira, F. M. Dirbas, D. L. Johnson, S. M. Swetter, R. W. Carlson, G. A. Fisher, A. Koong, S. Holmes, and P. P. Lee. 2009. Impaired interferon signaling is a common immune defect in human cancer. Proc. Natl. Acad. Sci. U. S. A. 106:9010-9105.
10. Daeffler, L., R. Horlein, J. Rommelaere, and J. P. Nuesch. 2003. Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region. J. Virol. 77:12466-12478.
11. Darrigrand, A. A., S. B. Singh, and C. M. Lang. 1984. Effects of Kilham rat virus on natural killer cell-mediated cytotoxicity in brown Norway and Wistar Furth rats. Am. J. Vet. Res. 45:200-202.
12. Deleu, L., A. Pujol, S. Faisst, and J. Rommelaere. 1999. Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection. J. Virol. 73:3877-3885. (Pubitemid 29189831)
13. Deonarain, R., A. Alcami, M. Alexiou, M. J. Dallman, D. R. Gewert, and A. C. Porter. 2000. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J. Virol. 74:3404-3409. (Pubitemid 30143766)
14. Der, S. D., and A. S. Lau. 1995. Involvement of the double-stranded-RNA- dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. U. S. A. 92:8841-8845.
15. Derbyshire, J. B. 1989. The interferon sensitivity of selected porcine viruses. Can. J. Vet. Res. 53:52-55.
16. Everts, B., and H. G. van der Poel. 2005. Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther. 12:141-161. (Pubitemid 40205096)
17. Gilfoy, F. D., and P. W. Mason. 2007. West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J. Virol. 81:11148-11458.
18. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464.
19. Haller, O., G. Kochs, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130. (Pubitemid 41814456)
20. Harris, R. E., P. H. Coleman, and P. S. Morahan. 1974. Erythrocyte association and interferon production by minute virus of mice. Proc. Soc Exp. Biol. Med. 145:1288-1292.
21. Hiscott, J. 2007. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490. (Pubitemid 47302822)
22. Hiscott, J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282:15325-15329.
23. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658.
24. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. (Pubitemid 44739521)
25. Hovanessian, A. G. 2007. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2′-5′oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 18:351-361.
26. Itah, R., J. Tal, and C. Davis. 2004. Host cell specificity of minute virus of mice in the developing mouse embryo. J. Virol. 78:9474-9486. (Pubitemid 39096555)
27. Johnston, J. B., S. H. Nazarian, R. Natale, and G. McFadden. 2005. Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virology 332:235-248.
28. Kawade, Y., and Y. Watanabe. 1987. Proc. Third Int. TNO Meet. Biol. Interferon Syst. Nijhoff, The Hague, The Netherlands.
29. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
30. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317-337.
31. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143:1-20.
32. Kestler, J., B. Neeb, S. Struyf, J. Van Damme, S. F. Cotmore, A. D'Abramo, P. Tattersall, J. Rommelaere, C. Dinsart, and J. J. Cornelis. 1999. cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Hum. Gene Ther. 10:1619-1632.
33. Kilham, L., C. E. Buckler, V. H. Ferm, and S. Baron. 1968. Production of interferon during rat virus infection. Proc. Soc Exp. Biol. Med. 129:274-278.
34. Lehtonen, A., S. Matikainen, and I. Julkunen. 1997. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol. 159:794-803. (Pubitemid 127484231)
35. Liu, T. C., and D. Kirn. 2007. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions. Cancer Res. 67:429-432.
36. Loving, C. L., S. L. Brockmeier, W. Ma, J. A. Richt, and R. E. Sacco. 2006. Innate cytokine responses in porcine macrophage populations: evidence for differential recognition of double-stranded RNA. J. Immunol. 177:8432-8439.
37. Nayak, R., and D. J. Pintel. 2007. Adeno-associated viruses can induce phosphorylation of eIF2α via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA. J. Virol. 81:11908-11916. (Pubitemid 47623822)
38. Nishiya, T., E. Kajita, S. Miwa, and A. L. Defranco. 2005. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280:37107-37117.
39. Pitha, P. M. 2000. Introduction: interferon's connection to cancer. Semin. Cancer Biol. 10:69-72.
40. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
41. Raykov, Z., S. Grekova, B. Leuchs, M. Aprahamian, and J. Rommelaere. 2008. Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity. Int. J. Cancer 122:2880-2884. (Pubitemid 351631394)
42. Rommelaere, J., and J. J. Cornelis. 1991. Antineoplastic activity of parvoviruses. J. Virol. Methods 33:233-251.
43. Saunders, L. R., and G. N. Barber. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961-983.
44. Schlehofer, J. R., M. Rentrop, and D. N. Mannel. 1992. Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin- 6 in mammalian cells. Med. Microbiol. Immunol. 181:153-164.
45. Schulz, O., S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom, and C. Reis e Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887-892.
46. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25:373-381.
47. Stojdl, D. F., B. Lichty, S. Knowles, R. Marius, H. Atkins, N. Sonenberg, and J. C. Bell. 2000. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6:821-825.
48. Stojdl, D. F., B. D. Lichty, B. R. tenOever, J. M. Paterson, A. T. Power, S. Knowles, R. Marius, J. Reynard, L. Poliquin, H. Atkins, E. G. Brown, R. K. Durbin, J. E. Durbin, J. Hiscott, and J. C. Bell. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
49. Takaoka, A., and S. Shinohara. 2008. DNA sensors in innate immune system. Uirusu 58:37-46.
50. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, Y. Ohba, and T. Taniguchi. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505. (Pubitemid 47123520)
51. Vercammen, E., J. Staal, and R. Beyaert. 2008. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin. Microbiol. Rev. 21:13-25.
52. Wang, F., J. W. Barrett, Y. Ma, G. A. Dekaban, and G. McFadden. 2009. Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized. J. Virol. 83:5928-5932.
53. Wang, Z., M. K. Choi, T. Ban, H. Yanai, H. Negishi, Y. Lu, T. Tamura, A. Takaoka, K. Nishikura, and T. Taniguchi. 2008. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc. Natl. Acad. Sci. U. S. A. 105:5477-5482.
54. Wiedbrauk, D. L., M. E. Bloom, and D. L. Lodmell. 1986. Mink parvoviruses and interferons: in vitro studies. J. Virol. 60:1179-1182.
55. Wiedbrauk, D. L., W. J. Hadlow, L. C. Ewalt, and D. L. Lodmell. 1986. Interferon response in normal and Aleutian disease virus-infected mink. J. Virol. 59:514-517.
56. Yoneyama, M., and T. Fujita. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29:178-181.
57. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
58. Yoshida, H., Y. Okabe, K. Kawane, H. Fukuyama, and S. Nagata. 2005. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6:49-56.
59. Zhu, J., X. Huang, and Y. Yang. 2009. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Invest. 119:2388-2398.
60. Zipris, D., E. Lien, A. Nair, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 2007. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J. Immunol. 178:693-701. (Pubitemid 46095141)
61. Zipris, D., E. Lien, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 2005. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174:131-142. (Pubitemid 40007399)
62. Zolotukhin, S., B. J. Byrne, E. Mason, I. Zolotukhin, M. Potter, K. Chesnut, C. Summerford, R. J. Samulski, and N. Muzyczka. 1999. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:973-985. (Pubitemid 29295202)